Integrated Analysis of the Expression Characteristics, Prognostic Value, and Immune Characteristics of PPARG in Breast Cancer

Abstract

Background: Breast cancer (BRCA) is the most frequent malignancy. Identification of potential biomarkers could help to better understand and combat the disease at early stages.Methods: We selected the overlapping genes of differential expressed genes and genes in BRCA-highly correlated modules by Weighted Gene Co-Expression Network Analysis (WGCNA) in TCGA and GEO data and performed KEGG and GO enrichment. PPARG was achieved from Protein-Protein Interaction (PPI) network analysis and prognostic analysis. TIMER, UALCAN, GEO, TCGA, and western blot analysis were used to validate the expression of PPARG in BRCA. PPARG was further analyzed by DNA methylation, immune parameters, and tumor mutation burden.Results: Among 381 overlapping genes, the lipid metabolic process was identified as highly enriched pathways in BRCA by TCGA and GEO data. When the prognostic analysis of 10 core genes by PPI network was performed, results revealed that high expression of PPARG was significantly correlated to a better prognosis. PPARG was lesser expression in BRCA according to TIMER, UALCAN, GEO, TCGA, and western blot in both mRNA level and protein level. PPARG had several high DNA methylation level sites and the methylation level is negatively correlated to expression. PPARG is also correlated to TNM stages, tumor microenvironment, and tumor burden.Conclusions: Findings of our study identified the PPARG as a potential biomarker by confirming its low expression in BRCA and its correlation to prognosis. Moreover, its correlation to DNA methylation and tumor microenvironment may guide new therapeutic strategies for BRCA patients.

Molecular basis of breast cancer with comorbid depression and the mechanistic insights of Xiaoyaosan in treating breast cancer-associated depression

“…Sufficient evidence supported that PPARG augmentation has a positive impact on multiple significant pathological processes in depression. [ 29 ] It was demonstrated that PPARG was a potential biomarker of BC and its gene expression was associated with BC prognosis, [ 30 ] although our prognosis analysis did not reach consistent results due to the stricter screening thresholds. Blocking PPARG interaction facilitates nuclear receptor subfamily 4 group A member 1 interdiction of fatty acid uptake and suppresses BC progression.…”

Circ-MEG3 inhibits the malignant proliferation of human cervical cancer cells

“…High expression of PPARγ was signi cantly associated with improved prognosis (20). Besides, study shows miR-494 upregulation was signi cantly associated with PTEN downregulation and inhibition of miR-494 suppressed cell proliferation and growth by directly targeting the 3'-untranslated region (3'-UTR) of PTEN mRNA (21).…”

METTL3 promotes drug resistance to oxaliplatin in gastric cancer cells through DNA repair pathway

“…Statistical analysis was performed using R version 4.1.2, and GraphPad Prism 8.0 ( Wang Q. et al, 2021 ; Wu et al, 2021 ; Fang et al, 2022 ; Liu et al, 2022 ). Each experiment was repeated independently a minimum of three times.…”